CY1106707T1 - Μεθοδοι κι εμβολια για παροχη in ovo προστασια εναντι ρινοτραχειιτιδας γαλοπουλας - Google Patents

Μεθοδοι κι εμβολια για παροχη in ovo προστασια εναντι ρινοτραχειιτιδας γαλοπουλας

Info

Publication number
CY1106707T1
CY1106707T1 CY20071100897T CY071100897T CY1106707T1 CY 1106707 T1 CY1106707 T1 CY 1106707T1 CY 20071100897 T CY20071100897 T CY 20071100897T CY 071100897 T CY071100897 T CY 071100897T CY 1106707 T1 CY1106707 T1 CY 1106707T1
Authority
CY
Cyprus
Prior art keywords
methods
vaccines
turkey rhinotracheitis
providing
protection against
Prior art date
Application number
CY20071100897T
Other languages
English (en)
Inventor
Frans Gerrit Davelaar
Original Assignee
Wyeth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22954857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1106707(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth filed Critical Wyeth
Publication of CY1106707T1 publication Critical patent/CY1106707T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Μέθοδοι και σκευάσματα για προστασία ξενιστών-πτηνών (π.χ. γαλοπούλων και/ή κοτόπουλων) από ιό ρινοτραχειίτιδας γαλοπούλας και/ή αναπνευστική ανεπάρκεια TRT ή SΗS με in ovo χορήγηση ζωντανών, μη μολυσματικών στελεχών του ΤRΤV σε κατάλληλα δοσολογικά επίπεδα ανά αβγό προσφέροντας αποδοτικό κι αποτελεσματικό εμβολιασμό που έχει αποδεκτά χαρακτηριστικά ασφάλειας κι αποτελεσματικότητας, κι επιπλέον προσφέρει υψηλότερους τίτλους σε εμβολιασμένα πουλιά από τα συμβατικώς χορηγούμενα εμβόλια.
CY20071100897T 2000-11-21 2007-07-05 Μεθοδοι κι εμβολια για παροχη in ovo προστασια εναντι ρινοτραχειιτιδας γαλοπουλας CY1106707T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25216200P 2000-11-21 2000-11-21
PCT/US2001/051207 WO2002045745A2 (en) 2000-11-21 2001-11-13 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis

Publications (1)

Publication Number Publication Date
CY1106707T1 true CY1106707T1 (el) 2012-05-23

Family

ID=22954857

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100897T CY1106707T1 (el) 2000-11-21 2007-07-05 Μεθοδοι κι εμβολια για παροχη in ovo προστασια εναντι ρινοτραχειιτιδας γαλοπουλας

Country Status (25)

Country Link
US (2) US20030054016A1 (el)
EP (1) EP1345658B1 (el)
JP (1) JP2004536780A (el)
KR (1) KR20030055314A (el)
CN (1) CN100379452C (el)
AR (1) AR031405A1 (el)
AT (1) ATE361120T1 (el)
AU (2) AU4342602A (el)
BG (1) BG107826A (el)
BR (1) BR0115507A (el)
CY (1) CY1106707T1 (el)
CZ (1) CZ20031419A3 (el)
DE (1) DE60128264T2 (el)
DK (1) DK1345658T3 (el)
ES (1) ES2284717T3 (el)
HK (1) HK1055914A1 (el)
HR (1) HRP20030508A2 (el)
HU (1) HUP0302343A2 (el)
MX (1) MXPA03004432A (el)
NZ (1) NZ526556A (el)
PL (1) PL365848A1 (el)
PT (1) PT1345658E (el)
WO (1) WO2002045745A2 (el)
YU (1) YU38503A (el)
ZA (1) ZA200304762B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115287270B (zh) * 2022-10-09 2023-01-06 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） B亚型禽偏肺病毒传代致弱株及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458630A (en) * 1982-06-22 1984-07-10 The United States Of America As Represented By The Secretary Of Agriculture Disease control in avian species by embryonal vaccination
ES2053732T3 (es) * 1987-05-21 1994-08-01 Know How Licensors Ltd Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
ES2070997T3 (es) * 1989-12-04 1995-06-16 Akzo Nobel Nv Virus de herpes recombinante de pavos y vacunas vector vivas derivadas de los mismos.
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
EP0696204A4 (en) * 1993-02-26 1999-03-31 Syntro Corp Recombined chickenpox virus and its use
US6136318A (en) 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
US6221361B1 (en) * 1995-01-19 2001-04-24 Syntro Corporation Recombinant swinepox virus
FR2750866B1 (fr) * 1996-06-27 1998-11-27 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
FR2751225B1 (fr) * 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2757061B1 (fr) * 1996-12-16 1999-03-26 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
EP0848956A1 (en) 1996-12-17 1998-06-24 Dimminaco Ag/Sa/Ltd. In ovo vaccination against Newcastle Disease
FR2758986B1 (fr) * 1997-01-31 1999-04-30 Rhone Merieux Vaccin vivant recombinant aviaire, utilisant comme vecteur le virus de la laryngotracheite infectieuse aviaire
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith
DK1259257T3 (da) 2000-02-29 2010-06-14 Wyeth Llc In-ovo beskyttelse mod infektiøs bronchitis

Also Published As

Publication number Publication date
US20030054016A1 (en) 2003-03-20
HUP0302343A2 (hu) 2003-10-28
AU2002243426B2 (en) 2007-05-17
HRP20030508A2 (en) 2004-08-31
DK1345658T3 (da) 2007-09-17
HK1055914A1 (en) 2004-01-30
AR031405A1 (es) 2003-09-24
YU38503A (sh) 2006-05-25
BR0115507A (pt) 2005-09-20
MXPA03004432A (es) 2003-08-19
DE60128264T2 (de) 2008-01-10
WO2002045745A2 (en) 2002-06-13
CN1486206A (zh) 2004-03-31
BG107826A (bg) 2004-02-27
ATE361120T1 (de) 2007-05-15
US20060034868A1 (en) 2006-02-16
WO2002045745A3 (en) 2002-11-28
EP1345658B1 (en) 2007-05-02
US7348012B2 (en) 2008-03-25
AU4342602A (en) 2002-06-18
CZ20031419A3 (cs) 2004-02-18
DE60128264D1 (de) 2007-06-14
KR20030055314A (ko) 2003-07-02
EP1345658A2 (en) 2003-09-24
JP2004536780A (ja) 2004-12-09
ZA200304762B (en) 2005-03-30
PL365848A1 (en) 2005-01-10
NZ526556A (en) 2006-06-30
ES2284717T3 (es) 2007-11-16
PT1345658E (pt) 2007-08-09
CN100379452C (zh) 2008-04-09

Similar Documents

Publication Publication Date Title
JP6313874B2 (ja) 感染性喉頭気管炎ウイルスおよびニューカッスル病ウイルス抗原をコードする組換え非病原性マレック病ウイルス構築物
CY1110544T1 (el) Προστασια εντος ωου εναντι λοιμωδους βρογχιτιδας
CA2080477A1 (en) Oral vaccine comprising antigen surface-associated with red blood cells
ES2118815T3 (es) Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
Dou et al. Maternal antibody induced by recombinant gp85 protein vaccine adjuvanted with CpG-ODN protects against ALV-J early infection in chickens
Peeters et al. Pulmonary immunization of chickens using non-adjuvanted spray-freeze dried whole inactivated virus vaccine completely protects against highly pathogenic H5N1 avian influenza virus
Jackwood What we know about avian coronavirus infectious bronchitis virus (IBV) in poultry and how that knowledge relates to the virus causing COVID-19 in humans
CY1106707T1 (el) Μεθοδοι κι εμβολια για παροχη in ovo προστασια εναντι ρινοτραχειιτιδας γαλοπουλας
BRPI0407948A (pt) vacina para uso na proteção de aves domésticas contra a bronquite infecciosa, método para a preparação da mesma, uso de cepa beaudette de ibv, e, método para a proteção de aves domésticas contra a bronquite infecciosa
JP4845874B2 (ja) 伝染性ファブリキウス嚢症ウイルスの抗原性分離株およびワクチン
WO2004030614A3 (en) Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
WO1998026800A1 (en) In ovo vaccination against newcastle disease
HUT62200A (en) Cell-free virus vaccine for marek disease
TN2014000393A1 (en) Modified marek's disease virus, and vaccines made therefrom
NZ510130A (en) Chicken anaemia viruses of low pathogenicity
Donahoe Inactivated avian influenza whole virus vaccines
TH62279A (th) วิธีการและวัคซีนสำหรับการจัดเตรียมการป้องกันในไข่ต่อต้านเทอร์คีไรโนทราคีไอติส
JPH07121874B2 (ja) 感染性気管支炎ワクチン
Banani et al. Research on production technology of avian imported vaccines.
Xiang et al. Next generation of rabies vaccines
US20040146530A1 (en) Avian vaccine effective against infectious bursal disease virus
RU2383357C1 (ru) Способ профилактики гриппа а птиц
MaloA et al. EFFICACY OF VACCINATION PROGRAMS BASED ON A HVT/ND-RECOMBINANT VACCINE AGAINST NEWCASTLE DISEASE AS AN ALTERNATIVE TO CONVENTIONAL PROGRAMS